newsJohnson & Johnson’s Ebola vaccine regimen, Zabdeno® and Mvabea®, generated…
15 September 2021 | By Anna Begley (European Pharmaceutical Review)
Johnson & Johnson’s Ebola vaccine regimen, Zabdeno® and Mvabea®, generated robust humoral immune responses in adults and children.